forty-two previously untreated patients with multiple myeloma were entered in a prospective , randomised trial comparing recombinant interferon alfa-2c monotherapy with vmcp ( vincristin , melphalan , cyclophosphamide and prednisolone ) .
C0026764
multiple myeloma
C0025241
melphalan